Simultaneously, they suppress NK cell cytotoxicity by downregulating activating receptors (e.g., NKG2D), reducing tissue damage in conditions like rheumatoid arthritis (RA) (Dehnavi et al., 2023). Here, KLRK1 is linked to rheumatoid arthritis.